These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10356737)

  • 1. [The efficacy and outlook for the study of live vaccines for the prevention of melioidosis].
    Iliukhin VI; Kislichkin NN; Merinova LK; Riapis LA; Denisov II; Farber SM; Kislichkina OI
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):49-51. PubMed ID: 10356737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The outlook for the development of live vaccines for the prevention of melioidosis].
    Iliukhin VI; Kislichkin NN; Merinova LK; Riapis LA; Denisov II; Farber SM; Kislichkina OI
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):52-5. PubMed ID: 10851991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study on the possibility of using live tularemia vaccine to increase resistance to heterologous infection disease].
    Iliukhin VI; Plekhanova NG; Senina TV; Stanovaia OV; Kislichkin NN
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (2):38-42. PubMed ID: 15188557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.
    Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW
    Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkholderia pseudomallei Δ
    Khakhum N; Bharaj P; Myers JN; Tapia D; Kilgore PB; Ross BN; Walker DH; Endsley JJ; Torres AG
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30602524
    [No Abstract]   [Full Text] [Related]  

  • 6. [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines].
    Manzeniuk IN; Galina EA; Dorokhin VV; Kalachev IIa; Borzenkov VN; Svetoch EA
    Antibiot Khimioter; 1999; 44(6):21-6. PubMed ID: 10422574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis.
    Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS
    Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T
    Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG
    mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice.
    Norris MH; Propst KL; Kang Y; Dow SW; Schweizer HP; Hoang TT
    Infect Immun; 2011 Oct; 79(10):4010-8. PubMed ID: 21807903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle.
    Breitbach K; Köhler J; Steinmetz I
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S89-94. PubMed ID: 19121696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Burkholderia mallei and pseudomallei vaccines.
    Silva EB; Dow SW
    Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global map of growth-regulated gene expression in Burkholderia pseudomallei, the causative agent of melioidosis.
    Rodrigues F; Sarkar-Tyson M; Harding SV; Sim SH; Chua HH; Lin CH; Han X; Karuturi RK; Sung K; Yu K; Chen W; Atkins TP; Titball RW; Tan P
    J Bacteriol; 2006 Dec; 188(23):8178-88. PubMed ID: 16997946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and characterization of an unmarked aroC deletion mutant of Burkholderia pseudomallei strain A2.
    Srilunchang T; Proungvitaya T; Wongratanacheewin S; Strugnell R; Homchampa P
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):123-30. PubMed ID: 19323044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.
    Lankelma JM; Wagemakers A; Birnie E; Haak BW; Trentelman JJA; Weehuizen TAF; Ersöz J; Roelofs JJTH; Hovius JW; Wiersinga WJ; Bins AD
    Virulence; 2017 Nov; 8(8):1683-1694. PubMed ID: 28323523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of RelA and SpoT in Burkholderia pseudomallei virulence and immunity.
    Müller CM; Conejero L; Spink N; Wand ME; Bancroft GJ; Titball RW
    Infect Immun; 2012 Sep; 80(9):3247-55. PubMed ID: 22778096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice.
    Chin CY; Tan SC; Nathan S
    Front Cell Infect Microbiol; 2012; 2():85. PubMed ID: 22919676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
    Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
    Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice.
    Su YC; Wan KL; Mohamed R; Nathan S
    Vaccine; 2010 Jul; 28(31):5005-11. PubMed ID: 20546831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis.
    Scott AE; Burtnick MN; Stokes MG; Whelan AO; Williamson ED; Atkins TP; Prior JL; Brett PJ
    Infect Immun; 2014 Aug; 82(8):3206-13. PubMed ID: 24866807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
    Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.